No Picture
News

Ionis presents new data demonstrating long-term disease control with DAWNZERA™ (donidalorsen) at ACAAI 2025 Annual Meeting

CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced new long-term data for DAWNZERA™ (donidalorsen), the first and only RNA-targeted prophylactic medicine for hereditary angioedema (HAE), to be presented at the 2025 American College of […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

ALZpath Proprietary pTau217 Antibody Wins BioTech Breakthrough Award for ‘Diagnostics Innovation of the Year’

Transformative Antibody Recognized for Advancing Global Alzheimer’s Disease Detection CARLSBAD, Calif., Nov. 6, 2025 /PRNewswire/ — ALZpath, Inc., a leading developer of innovative diagnostic tools for Alzheimer’s disease, today announced it has been named the […]

No Picture
News

Arima Genomics Wins BioTech Breakthrough Award For “Clinical Diagnostics Solution of the Year”

CARLSBAD, Calif.–(BUSINESS WIRE)– #ArimaGenomics–Arima Genomics has been named the winner of the BioTech Breakthrough Award for “Clinical Diagnostics Solution of the Year.” Click here to view original post Click Here to Publish/Feature Your Company or […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Abzena and Mabqi Announce Strategic Partnership to Offer Integrated Discovery through Development Solution

SAN DIEGO and MONTPELLIER, France, Nov. 6, 2025 /PRNewswire/ — Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotechnology company focused on the discovery and development of fully human […]

No Picture
News

Acadia Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operating Overview

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the third quarter ended September 30, 2025. “Acadia delivered another strong quarter, generating total revenue of $278.6 million,” said Catherine Owen Adams, […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Halozyme Therapeutics, Inc. Announces Proposed Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032

SAN DIEGO, Nov. 5, 2025 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme” or the “Company”), today announced that it intends to offer, subject to market conditions and other factors, $650 million aggregate principal amount […]

No Picture
News

Illumina and Grail Veterans Launch Hepta With First Liquid Biopsy-Native AI That Detects Liver Disease With Tissue-Level Biological Insights

FOSTER CITY, Calif.–(BUSINESS WIRE)–Hepta, a biotechnology company using transformer-based AI to read the cell-free DNA (cfDNA) epigenome and detect organ-specific signals of chronic disease, today emerged from stealth with $6.7 million in seed funding led […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Skye Bioscience to Announce Third Quarter 2025 Financial Results and Business Update on November 10, 2025

SAN DIEGO, Nov. 05, 2025 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on advancing new therapeutic pathways for obesity and other metabolic health disorders, will host a conference call […]

No Picture
News

BioAtla to Announce Third Quarter 2025 Financial Results and Provide Business Highlights on November 13, 2025

SAN DIEGO, Nov. 05, 2025 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today […]

No Picture
News

AMP 2025: DNAe to unveil latest data from world’s first NGS-based, fully automated sample-to-result diagnostic platform

Poster presentations will preview new data from breakthrough bloodstream infection detection and oncology tests running on first-of-its-kind Lilia-SEQ™ platform LONDON and CARLSBAD, Calif., Nov. 5, 2025 /PRNewswire/ — DNAe, the Next-Generation Sequencing (NGS) company developing […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Catalent’s SMARTag® ADC Pipeline and New Enhanced Conjugates Offering Featured at 16th World ADC San Diego

TAMPA, Fla.–(BUSINESS WIRE)–Catalent, Inc. presented new advancements in its SMARTag® antibody-drug conjugate (ADC) technology at the 16th World ADC San Diego conference. Click here to view original post Click Here to Publish/Feature Your Company or […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Calidi Biotherapeutics Announces Investor Event to be Held on Friday, November 7th at the 2025 SITC Annual Meeting

SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, targeted genetic medicines, today announced that it […]


ADVERTISEMENT — Advertise With Biotech Networks
News

BrainXell Therapeutics Unveils Promising Preclinical Data Demonstrating Efficacy of BXT-110, an Autologous iPSC-Derived Neuronal Therapy, in Parkinson’s Disease

SAN DIEGO, Nov. 3, 2025 /PRNewswire/ — BrainXell Therapeutics today announced the disclosure of its first scientific data, which will be presented at two conferences this month: the Cell Symposia | Gene and Cell-Based Therapies: […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results

SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced […]

No Picture
News

ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results

SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to […]